Breast Cancer
Conference Coverage
Breast cancer hormone therapy may affect cognitive function
Major finding: The odds of any decline in cognitive function were significantly higher in patients on hormone therapy (OR, 7.7), compared with...
News
Many women with cancer not told about impaired fertility risk
Major finding: Less than half of all women of reproductive age with a diagnosis of cancer were told by physicians that treatment might affect...
News
Internal mammary chain radiation ups breast cancer survival
Major finding: Ten-year overall survival was 82.3% with internal mammary and medial supraclavicular radiation therapy vs.
News
Jumping the gun on contralateral prophylactic mastectomy?
News
False-negative rate for sentinel nodes high after neoadjuvant chemotherapy
Major finding: Sentinel lymph node findings had a false-negative rate of 12.6% among women with cN1 breast cancer, after neoadjuvant chemotherapy...
News
BMN 673 monotherapy makes splash in BRCA-mutated ovarian, breast cancer
Major finding: The RECIST response rate was 44% for breast and ovarian cancer patients.Data source: Ongoing phase I/II study in ovarian and breast...
News
Everolimus effective in women with early failure of adjuvant therapy
Major finding: Median progression-free survival was 11.5 months in the everolimus-plus-exemestane group and 4.1 months in the placebo-plus...
Conference Coverage
ASTRO outlines five radiation oncology practices that should be curtailed
News
USPSTF breast cancer chemoprevention recommendations: We’re in this together
Major finding: Asymptomatic women without a prior diagnosis of breast cancer, ductal carcinoma in situ, or lobular carcinoma in situ who are at...
Conference Coverage
Breast cancer receptor change may predict outcomes
Major finding: Receptor status changed in 41% of breast cancers after neoadjuvant chemotherapy.